The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adoptive transfer of tumor-infiltrating lymphocytes in patients with sarcomas, ovarian, and pancreatic cancers.
 
Rodabe Navroze Amaria
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); iovance Biotherapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Chantale Bernatchez
Stock and Other Ownership Interests - Lexicon (I)
Research Funding - EMD Serono; Idera; Iovance Biotherapeutics; MedImmune; Nektar; Pfizer
Patents, Royalties, Other Intellectual Property - Patent pending on BTLA as a marker for better CD8 T cells for adoptive immunotherapy
 
Marie-Andree Forget
No Relationships to Disclose
 
Cara L. Haymaker
Research Funding - Idera; Nektar
 
Anthony Paul Conley
Consulting or Advisory Role - Nektar; Novartis
Research Funding - Ignyta; Iovance Biotherapeutics (Inst); MedImmune (Inst)
 
J. Andrew Livingston
No Relationships to Disclose
 
Gauri Rajani Varadhachary
Employment - Fannin Partners (I)
Leadership - Fannin Partners (I); Pulmotect (I)
Stock and Other Ownership Interests - Fannin Partners (I)
Honoraria - ARMO BioSciences; Celgene; Merrimack; Momenta Pharmaceuticals; Rexahn Pharmaceuticals; SOBI
Consulting or Advisory Role - Celgene; Merrimack; Momenta Pharmaceuticals; Rexahn Pharmaceuticals
Research Funding - Merck (Inst); Parker Institute for Cancer Immunotherapy
Patents, Royalties, Other Intellectual Property - Spouse is an inventor of use patents relating to recombinant human lactoferrin. The molecule is no longer in development and patents are being allowed to lapse as payments come due. (I); Spouse is inventor on a pending patent for an ELISA diagnostic platform. Not related to my area of research. (I)
Travel, Accommodations, Expenses - Celgene; Merrimack; SOBI
 
Milind M. Javle
Other Relationship - Bayer; BeiGene; Incyte; Merck; Merck Serono; Novartis; Pieris Pharmaceuticals; QED Therapeutics; Rafael Pharmaceuticals; Seagen
 
Anirban Maitra
Honoraria - Celgene
 
Ching-Wei David Tzeng
Honoraria - Surgical Pain Consortium; Worrell
Research Funding - PanTher Therapeutics
Travel, Accommodations, Expenses - AngioDynamics; Intuitive Surgical
 
Emily Hinchcliff
No Relationships to Disclose
 
Virginia Bayer
No Relationships to Disclose
 
Yvonne Gasior
No Relationships to Disclose
 
Tyler Hilton
No Relationships to Disclose
 
Joseph Celestino
No Relationships to Disclose
 
Kelly M Rangel
No Relationships to Disclose
 
Ying Yuan
Honoraria - Ono Pharmaceutical
Consulting or Advisory Role - Boehringer Ingelheim; Midas Medical Technologies; Salzman Group
 
Karen H. Lu
No Relationships to Disclose
 
Patrick Hwu
Stock and Other Ownership Interests - Immatics
Consulting or Advisory Role - Dragonfly Therapeutics; GlaxoSmithKline; Immatics; Sanofi
Research Funding - Genentech (Inst)
 
Amir A. Jazaeri
Honoraria - Gerson Lehrman Group
Consulting or Advisory Role - Almac Group; Aravive; Genentech/Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); immatics (Inst); Iovance Biotherapeutics (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune